|
1
|
Lee RC, Feinbaum RL and Ambros V: The
C. elegans heterochronic gene lin-4 encodes small RNAs with
antisense complementarity to lin-14. Cell. 75:843–854.
1993.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Hudson RS, Yi M, Esposito D, Watkins SK,
Hurwitz AA, Yfantis HG, Lee DH, Borin JF, Naslund MJ, Alexander RB,
et al: MicroRNA-1 is a candidate tumor suppressor and prognostic
marker in human prostate cancer. Nucleic Acids Res. 40:3689–3703.
2012.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Hudson RS, Yi M, Esposito D, Glynn SA,
Starks AM, Yang Y, Schetter AJ, Watkins SK, Hurwitz AA, Dorsey TH,
et al: MicroRNA-106b-25 cluster expression is associated with early
disease recurrence and targets caspase-7 and focal adhesion in
human prostate cancer. Oncogene. 32:4139–4147. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ambs S, Prueitt RL, Yi M, Hudson RS, Howe
TM, Petrocca F, Wallace TA, Liu CG, Volinia S, Calin GA, et al:
Genomic profiling of microRNA and messenger RNA reveals deregulated
microRNA expression in prostate cancer. Cancer Res. 68:6162–6170.
2008.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Taylor BS, Schultz N, Hieronymus H,
Gopalan A, Xiao Y, Carver BS, Arora VK, Kaushik P, Cerami E, Reva
B, et al: Integrative genomic profiling of human prostate cancer.
Cancer Cell. 18:11–22. 2010.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Schultz NA, Andersen KK, Roslind A,
Willenbrock H, Wojdemann M and Johansen JS: Prognostic microRNAs in
cancer tissue from patients operated for pancreatic cancer-five
microRNAs in a prognostic index. World J Surg. 36:2699–2707.
2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Xie H, Lee L, Caramuta S, Höög A, Browaldh
N, Björnhagen V, Larsson C and Lui WO: MicroRNA expression patterns
related to merkel cell polyomavirus infection in human merkel cell
carcinoma. J Invest Dermatol. 134:507–517. 2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Gasparini P, Cascione L, Landi L, Carasi
S, Lovat F, Tibaldi C, Alì G, D'Incecco A, Minuti G, Chella A, et
al: MicroRNA classifiers are powerful diagnostic/prognostic tools
in ALK-, EGFR-, and KRAS-driven lung cancers. Proc Natl Acad Sci
USA. 112:14924–14929. 2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Yang Z, He J, Gao P, Niu Y, Zhang J, Wang
L, Liu M, Wei X, Liu C, Zhang C, et al: miR-769-5p suppressed cell
proliferation, migration and invasion by targeting TGFBR1 in
non-small cell lung carcinoma. Oncotarget. 8:113558–113570.
2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Luo N, Guo J, Chen L, Yang W, Qu X and
Cheng Z: ARHGAP10, downregulated in ovarian cancer, suppresses
tumorigenicity of ovarian cancer cells. Cell Death Dis.
7(e2157)2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Gong H, Chen X, Jin Y, Lu J, Cai Y, Wei O,
Zhao J, Zhang W, Wen X, Wang Y and Chen W: Expression of ARHGAP10
correlates with prognosis of prostate cancer. Int J Clin Exp
Pathol. 12:3839–3846. 2019.PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Grasso CS, Wu YM, Robinson DR, Cao X,
Dhanasekaran SM, Khan AP, Quist MJ, Jing X, Lonigro RJ, Brenner JC,
et al: The mutational landscape of lethal castration-resistant
prostate cancer. Nature. 487:239–243. 2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Lapointe J, Li C, Higgins JP, van de Rijn
M, Bair E, Montgomery K, Ferrari M, Egevad L, Rayford W, Bergerheim
U, et al: Gene expression profiling identifies clinically relevant
subtypes of prostate cancer. Proc Natl Acad Sci USA. 101:811–816.
2004.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Singh D, Febbo PG, Ross K, Jackson DG,
Manola J, Ladd C, Tamayo P, Renshaw AA, D'Amico AV, Richie JP, et
al: Gene expression correlates of clinical prostate cancer
behavior. Cancer Cell. 1:203–209. 2002.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Cancer Genome Atlas Research Network. The
molecular taxonomy of primary prostate cancer. Cell. 163:1011–1025.
2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Tomlins SA, Mehra R, Rhodes DR, Cao X,
Wang L, Dhanasekaran SM, Kalyana-Sundaram S, Wei JT, Rubin MA,
Pienta KJ, et al: Integrative molecular concept modeling of
prostate cancer progression. Nat Genet. 39:41–51. 2007.PubMed/NCBI View
Article : Google Scholar
|
|
18
|
Wallace TA, Prueitt RL, Yi M, Howe TM,
Gillespie JW, Yfantis HG, Stephens RM, Caporaso NE, Loffredo CA and
Ambs S: Tumor immunobiological differences in prostate cancer
between African-American and European-American men. Cancer Res.
68:927–936. 2008.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Yu YP, Landsittel D, Jing L, Nelson J, Ren
B, Liu L, McDonald C, Thomas R, Dhir R, Finkelstein S, et al: Gene
expression alterations in prostate cancer predicting tumor
aggression and preceding development of malignancy. J Clin Oncol.
22:2790–2799. 2004.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kong W, He L, Richards EJ, Challa S, Xu
CX, Permuth-Wey J, Lancaster JM, Coppola D, Sellers TA, Djeu JY and
Cheng JQ: Upregulation of miRNA-155 promotes tumour angiogenesis by
targeting VHL and is associated with poor prognosis and
triple-negative breast cancer. Oncogene. 33:679–689.
2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Gu Y, Liu S, Zhang X, Chen G, Liang H, Yu
M, Liao Z, Zhou Y, Zhang CY, Wang T, et al: Oncogenic miR-19a and
miR-19b co-regulate tumor suppressor MTUS1 to promote cell
proliferation and migration in lung cancer. Protein Cell.
8:455–466. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Long MD, Singh PK, Russell JR, Llimos G,
Rosario S, Rizvi A, van den Berg PR, Kirk J, Sucheston-Campbell LE,
Smiraglia DJ and Campbell MJ: The miR-96 and RARγ signaling axis
governs androgen signaling and prostate cancer progression.
Oncogene. 38:421–444. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ren D, Yang Q, Dai Y, Guo W, Du H, Song L
and Peng X: Oncogenic miR-210-3p promotes prostate cancer cell EMT
and bone metastasis via NF-κB signaling pathway. Mol Cancer.
16(117)2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Barros-Silva D, Costa-Pinheiro P, Duarte
H, Sousa EJ, Evangelista AF, Graça I, Carneiro I, Martins AT,
Oliveira J, Carvalho AL, et al: MicroRNA-27a-5p regulation by
promoter methylation and MYC signaling in prostate carcinogenesis.
Cell Death Dis. 9(167)2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Huang Q, Ma B, Su Y, Chan K, Qu H, Huang
J, Wang D, Qiu J, Liu H, Yang X and Wang Z: miR-197-3p represses
the proliferation of prostate cancer by regulating the
VDAC1/AKT/β-catenin signaling axis. Int J Biol Sci. 16:1417–1426.
2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Geng Y, Deng L, Su D, Xiao J, Ge D, Bao Y
and Jing H: Identification of crucial microRNAs and genes in
hypoxia-induced human lung adenocarcinoma cells. Onco Targets Ther.
9:4605–4616. 2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Chen S, Evans HG and Evans DR:
FAM129B/MINERVA, a novel adherens junction-associated protein,
suppresses apoptosis in HeLa cells. J Biol Chem. 286:10201–10209.
2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Detournay O and Weis VM: Role of the
sphingosine rheostat in the regulation of cnidarian-dinoflagellate
symbioses. Biol Bull. 221:261–269. 2011.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Hug H, Los M, Hirt W and Debatin KM:
Rhodamine 110-linked amino acids and peptides as substrates to
measure caspase activity upon apoptosis induction in intact cells.
Biochemistry. 38:13906–13911. 1999.PubMed/NCBI View Article : Google Scholar
|
